Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • gwilymh
    Member
    • Dec 2011
    • 72

    How do you identify the specific start and stop locations of mitochondrial genes

    Hi,

    I am currently annotating a mitochondrial genome in Geneious. The genome was assembled using next-generation sequence data from one species, with the published mitochondrial genome of a closely related species used as a reference genome (NCBI reference HQ332445). The assembled and reference genomes are very similar, and the annotations from the reference genome seem to be quite transferable to the newly assembled genome (Geneious has functions for transferring annotations from a reference gene sequence to a consensus gene sequence; including generating translated protein sequences from cds).

    I have noticed, however, that 3 or 4 of the mitochondrial coding genes in both the reference mitochondrial genome and the assembled mitochondrial genome do not actually start with start codons (ATG). There are start codons maybe 30-50 bases upstream of the start. I ran a quick BLAST search on the DNA and protein sequences of these genes, and got hits consistent with their current annotations.

    Could the gene start positions have been misidentified by the researchers who originally annotated the reference mitochondrial genome? Surely all coding genes have to start with a start codon? Does this mean that the other gene locations on the reference mitochondrial genome could be inaccurate?

    Are there any general guidelines/rules of thumb/ best practices for identifying where exactly genes start and stop on the mitochondrial chromosome?

    I am still fairly new to annotating genes, so any general or specific suggestions are welcome.
  • dsenalik
    Carrot Scientist
    • Nov 2009
    • 42

    #2
    I wonder how correctly your reference genome is annotated. Perhaps it was annotated by blast hits, ignoring ORFs.
    And was it sequenced with a "homopolymer-susceptible" technology such as 454 or Ion torrent?

    Our own question/dilemma in this same situation is whether it is scientifically acceptable/morally correct to adjust these homopolymer "errors" based only on ORF disruption.

    e.g. "Well, the assembler says seven "A"s, but if it was eight, the ORF is correct, and 40% of the reads say eight"

    But, of course, we should really design primers and check the regions in question, or just do an Illumina run. But, that costs more money. Still, that's what we will probably have to do.

    I ramble, but I shall follow this thread with interest.

    Comment

    Latest Articles

    Collapse

    • mylaser
      Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by mylaser
      Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
      The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
      Whether you're exploring Kheloyaar for the first time or want to understand...
      Yesterday, 09:27 PM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      Yesterday, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:04 AM
    0 responses
    8 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    7 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-02-2026, 11:08 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Working...